Abstract
Males acquire calcific aortic valve disease (CAVD) twice as often as females, yet stenotic valves from females display significantly higher levels of fibrosis compared to males with similar extent of disease. Fibrosis occurs as an imbalance between the production and degradation of the extracellular matrix (ECM), specifically type I collagen. This work characterizes ECM production and remodeling by male and female valvular interstitial cells (VICs) to better understand the fibrocalcific divergence between sexes evident in CAVD. Male and female VICs were assessed for gene and protein expression of myofibroblastic markers, ECM components, matrix metalloproteinases (MMPs), and tissue inhibitors of MMPs (TIMPs) via qRT-PCR and western blot. Overall metabolic activity was also measured. Activity assays for collagenase and gelatinase were performed to examine degradation behavior. Male VICs produced greater levels of myofibroblastic markers while female VICs showed greater metabolic activity and collagen production. In general, females displayed a greater level of MMP expression and production than males, but no sex differences were observed in TIMP production. Male VICs also displayed a greater level of collagenase and gelatinase activity than female VICs. This work displays sex differences in ECM remodeling by VICs that could be related to the sexual dimorphism in ECM structure seen in clinical CAVD.
Similar content being viewed by others
References
Lindman BR, Clavel MA, Mathieu P, Iung B, Lancellotti P, Otto CM, Pibarot P (2016) Calcific aortic stenosis. Nat Rev Dis Prim 2(1):16006
Liu AC, Joag VR, Gotlieb AI (2007) The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am J Pathol 171(5):1407–1418
Mccoy CM, Nicholas DQ, Masters KS (2012) Sex-related differences in gene expression by porcine aortic valvular interstitial cells. PLoS ONE 7(7):e39980
Summerhill VI, Moschetta D, Orekhov AN, Poggio P, Myasoedova VA (2020) Sex-specific features of calcific aortic valve disease. Int J Mol Sci 21(16):5620
Cote N, Clavel MA (2020) Sex differences in the pathophysiology, diagnosis, and management of aortic stenosis. Cardiol Clin 38(1):129–138
Thaden JJ, Nkomo VT, Suri RM, Maleszewski JJ, Soderberg DJ, Clavel MA, Pislaru SV, Malouf JF, Foley TA, Oh JK, Miller JD, Edwards WD, Enriquez-Sarano M (2016) Sex-related differences in calcific aortic stenosis: correlating clinical and echocardiographic characteristics and computed tomography aortic valve calcium score to excised aortic valve weight. Eur Heart J 37(8):693–699
Porras AM, McCoy CM, Masters KS (2017) Calcific aortic valve disease: a battle of the sexes. Circ Res 120(4):604–606
Simard L, Cote N, Dagenais F, Mathieu P, Couture C, Trahan S, Bosse Y, Mohammadi S, Page S, Joubert P, Clavel MA (2017) Sex-related discordance between aortic valve calcification and hemodynamic severity of aortic stenosis: is valvular fibrosis the explanation? Circ Res 120(4):681–691
Voisine M, Hervault M, Shen M, Boilard AJ, Filion B, Rosa M, Bosse Y, Mathieu P, Cote N, Clavel MA (2020) Age, sex, and valve phenotype differences in fibro-calcific remodeling of calcified aortic valve. J Am Heart Assoc 9(10):e015610
Di Vito A, Donato A, Presta I, Mancuso T, Brunetti FS, Mastroroberto P, Amorosi A, Malara N, Donato G (2021) Extracellular matrix in calcific aortic valve disease: architecture, dynamic and perspectives. Int J Mol Sci 22(2):913
Stephens EH, Saltarrelli JG, Baggett LS, Nandi I, Kuo JJ, Davis AR, Olmsted-Davis EA, Reardon MJ, Morrisett JD, Grande-Allen KJ (2011) Differential proteoglycan and hyaluronan distribution in calcified aortic valves. Cardiovasc Pathol 20(6):334–342
Artiach G, Carracedo M, Seime T, Plunde O, Laguna-Fernandez A, Matic L, Franco-Cereceda A, Back M (2020) Proteoglycan 4 is increased in human calcified aortic valves and enhances valvular interstitial cell calcification. Cells 9(3):684
Hutson HN, Marohl T, Anderson M, Eliceiri K, Campagnola P, Masters KS (2016) Calcific aortic valve disease is associated with layer-specific alterations in collagen architecture. PLoS ONE 11(9):e0163858
Kaden JJ, Vocke DC, Fischer CS, Grobholz R, Brueckmann M, Vahl CF, Hagl S, Haase KK, Dempfle CE, Borggrefe M (2004) Expression and activity of matrix metalloproteinase-2 in calcific aortic stenosis. Z Kardiol 93(2):124–130
Edep ME, Shirani J, Wolf P, Brown DL (2000) Matrix metalloproteinase expression in nonrheumatic aortic stenosis. Cardiovasc Pathol 9(5):281–286
Masjedi S, Lei Y, Patel J, Ferdous Z (2017) Sex-related differences in matrix remodeling and early osteogenic markers in aortic valvular interstitial cells. Heart Vessel 32(2):217–228
Walker GA, Masters KS, Shah DN, Anseth KS, Leinwand LA (2004) Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease. Circ Res 95(3):253–260
Cote N, El Husseini D, Pepin A, Guauque-Olarte S, Ducharme V, Bouchard-Cannon P, Audet A, Fournier D, Gaudreault N, Derbali H, McKee MD, Simard C, Despres JP, Pibarot P, Bosse Y, Mathieu P (2012) ATP acts as a survival signal and prevents the mineralization of aortic valve. J Mol Cell Cardiol 52(5):1191–1202
Katz R, Wong ND, Kronmal R, Takasu J, Shavelle DM, Probstfield JL, Bertoni AG, Budoff MJ, O’Brien KD (2006) Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the multi-ethnic study of atherosclerosis. Circulation 113(17):2113–2119
Roberts F, Markby G, Dillon S, Farquharson C, MacRae VE (2020) Beyond mineralisation: metabolic functions for matrix mineralisation regulators. J Endocrinol 245(2):R11–R22
Valiente-Alandi I, Potter SJ, Salvador AM, Schafer AE, Schips T, Carrillo-Salinas F, Gibson AM, Nieman ML, Perkins C, Sargent MA, Huo J, Lorenz JN, DeFalco T, Molkentin JD, Alcaide P, Blaxall BC (2018) Inhibiting fibronectin attenuates fibrosis and improves cardiac function in a model of heart failure. Circulation 138(12):1236–1252
Li LC, Li J, Gao J (2014) Functions of galectin-3 and its role in fibrotic diseases. J Pharmacol Expr Ther 351(2):336–343
Sadaba JR, Martinez-Martinez E, Arrieta V, Alvarez V, Fernandez-Celis A, Ibarrola J, Melero A, Rossignol P, Cachofeiro V, Lopez-Andres N (2016) Role for galectin-3 in calcific aortic valve stenosis. J Am Heart Assoc 5(11):e004360
Go JL, Prem K, Al-Hijji MA, Qin Q, Noble C, Young MD, Lerman LO, Lerman A (2018) Experimental metabolic syndrome model associated with mechanical and structural degenerative changes of the aortic valve. Sci Rep 8(1):17835
Sarajlic P, Plunde O, Franco-Cereceda A, Back M (2021) Artificial intelligence models reveal sex-specific gene expression in aortic valve calcification. JACC Basic Transl Sci 6(5):403–412
Capoulade R, Clavel MA, Dumesnil JG, Chan KL, Teo KK, Tam JW, Cote N, Mathieu P, Despres JP, Pibarot P, Investigators A (2012) Impact of metabolic syndrome on progression of aortic stenosis: influence of age and statin therapy. J Am Coll Cardiol 60(3):216–223
Garate-Carrillo A, Gonzalez J, Ceballos G, Ramirez-Sanchez I, Villarreal F (2020) Sex related differences in the pathogenesis of organ fibrosis. Transl Res 222:41–55
Duprez DA, Gross MD, Kizer JR, Ix JH, Hundley WG, Jacobs DR Jr (2018) Predictive value of collagen biomarkers for heart failure with and without preserved ejection fraction: MESA (multi-ethnic study of atherosclerosis). J Am Heart Assoc 7(5):e007885
Barasch E, Gottdiener JS, Aurigemma G, Kitzman DW, Han J, Kop WJ, Tracy RP (2011) The relationship between serum markers of collagen turnover and cardiovascular outcome in the elderly: the cardiovascular health study. Circulation 4(6):733–739
Li Z, Wang Z, Yin Z, Zhang Y, Xue X, Han J, Zhu Y, Zhang J, Emmert MY, Wang H (2017) Gender differences in fibrosis remodeling in patients with long-standing persistent atrial fibrillation. Oncotarget 8(32):53714–53729
Gharaee-Kermani M, Hatano K, Nozaki Y, Phan SH (2005) Gender-based differences in bleomycin-induced pulmonary fibrosis. Am J Pathol 166(6):1593–1606
Rodriguez KJ, Piechura LM, Porras AM, Masters KS (2014) Manipulation of valve composition to elucidate the role of collagen in aortic valve calcification. BMC Cardiovasc Disord 14:29
Monzack EL, Gu X, Masters KS (2009) Efficacy of simvastatin treatment of valvular interstitial cells varies with the extracellular environment. Arterioscler Thromb Vasc Biol 29(2):246–253
Matilla L, Roncal C, Ibarrola J, Arrieta V, Garcia-Pena A, Fernandez-Celis A, Navarro A, Alvarez V, Gainza A, Orbe J, Cachofeiro V, Zalba G, Sadaba R, Rodriguez JA, Lopez-Andres N (2020) A role for MMP-10 (matrix metalloproteinase-10) in calcific aortic valve stenosis. Arterioscler Thromb Vasc Biol 40(5):1370–1382
Freeman RV, Otto CM (2005) Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 111(24):3316–3326
Leopold JA (2012) Cellular mechanisms of aortic valve calcification. Circulation 5(4):605–614
Acknowledgements
Not applicable.
Funding
This work was supported by grants from the NIH (R01 HL141181 and R21 EB019508 to K.S.M. and TL1TR002375 to A.J.S.) and the UW-Madison Graduate Engineering Research Scholars (GERS) Program. This material is based upon work supported by the National Science Foundation under Grant No. 1400815. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation.
Author information
Authors and Affiliations
Contributions
LS, AS, LFR, JZ, and KM participated in study design and data analysis. LS, AS, and KM drafted the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Ethical approval
No animal or human subjects were used in this work. All cells were derived from surplus animal tissues acquired from a local butcher.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Simon, L.R., Scott, A.J., Figueroa Rios, L. et al. Cellular-scale sex differences in extracellular matrix remodeling by valvular interstitial cells. Heart Vessels 38, 122–130 (2023). https://doi.org/10.1007/s00380-022-02164-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-022-02164-2